NIVF vs. PBM, CERO, SSY, THAR, PEAR, XCUR, GTBP, TMDIF, ALZN, and SNGX
Should you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Psyence Biomedical (PBM), CERo Therapeutics (CERO), SunLink Health Systems (SSY), Tharimmune (THAR), Pear Therapeutics (PEAR), Exicure (XCUR), GT Biopharma (GTBP), Titan Medical (TMDIF), Alzamend Neuro (ALZN), and Soligenix (SNGX). These companies are all part of the "medical" sector.
NewGenIvf Group (NASDAQ:NIVF) and Psyence Biomedical (NASDAQ:PBM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, community ranking, institutional ownership, dividends, analyst recommendations, risk and earnings.
NewGenIvf Group and Psyence Biomedical both received 0 outperform votes by MarketBeat users.
In the previous week, Psyence Biomedical had 1 more articles in the media than NewGenIvf Group. MarketBeat recorded 1 mentions for Psyence Biomedical and 0 mentions for NewGenIvf Group. NewGenIvf Group's average media sentiment score of 0.00 equaled Psyence Biomedical'saverage media sentiment score.
NewGenIvf Group has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500. Comparatively, Psyence Biomedical has a beta of -0.11, suggesting that its share price is 111% less volatile than the S&P 500.
66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 77.4% of Psyence Biomedical shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by insiders. Comparatively, 3.6% of Psyence Biomedical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
NewGenIvf Group beats Psyence Biomedical on 3 of the 5 factors compared between the two stocks.
Get NewGenIvf Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NewGenIvf Group Competitors List
Related Companies and Tools
